Related Experiment Videos
Harmonized microarray/mutation scanning analysis of TP53 mutations in undissected colorectal tumors
Reyna Favis1, Jianmin Huang, Norman P Gerry
1Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, USA.
Human Mutation
|June 29, 2004
Summary
Detecting TP53 mutations in colorectal cancer is crucial for prognosis and therapy response. A new harmonized protocol accurately identifies TP53 mutations without tumor cell enrichment, improving molecular profiling of solid tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- TP53 mutations influence tumor prognosis and therapeutic responses.
- Detecting TP53 mutations in solid tumors is challenging due to wild-type DNA interference.
Purpose of the Study:
- To identify TP53 mutations in colorectal adenocarcinomas and liver metastases without prior tumor cell enrichment.
- To develop and validate a harmonized protocol for TP53 mutation detection.
Main Methods:
- A harmonized protocol using multiplex polymerase chain reaction/ligase detection reaction (PCR/LDR) with Universal DNA microarray analysis and endonuclease V/ligase mutation scanning was developed.
- Sequences were verified using dideoxy sequencing.
- The protocol was applied to 138 stage I-IV colorectal adenocarcinomas and liver metastases.
Main Results:
- The harmonized protocol successfully detected all 66 TP53 mutations.
- Dideoxy sequencing detected 62% of mutations with automated reading and 89% with manual reading.
- The distribution and types of TP53 mutations were comparable to existing colon cancer data.
Conclusions:
- The developed harmonized protocol is effective for detecting TP53 mutations in colorectal cancer without microdissection.
- This method improves molecular profiling of solid tumors by overcoming challenges posed by wild-type DNA.
- The findings support the clinical relevance of TP53 mutational status in colorectal cancer management.